share_log

AssetMark Financial Hldgs Analyst Ratings

Benzinga ·  Nov 7, 2023 12:37
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
11/07/2023 28.35% BMO Capital $33 → $32 Maintains Market Perform
10/11/2023 44.39% Raymond James $38 → $36 Maintains Strong Buy
07/12/2023 52.41% Raymond James $37 → $38 Maintains Strong Buy
06/05/2023 20.33% Jefferies $31 → $30 Maintains Hold
05/04/2023 40.38% Credit Suisse $34 → $35 Maintains Outperform
04/11/2023 48.4% Raymond James $32 → $37 Maintains Strong Buy
02/23/2023 12.31% Credit Suisse $23 → $28 Maintains Outperform
01/23/2023 28.35% JP Morgan $24 → $32 Upgrades Neutral → Overweight
01/11/2023 28.35% Raymond James $30 → $32 Maintains Strong Buy
11/02/2022 20.33% Raymond James $29 → $30 Maintains Strong Buy
10/11/2022 16.32% Raymond James $30 → $29 Maintains Strong Buy
07/12/2022 20.33% Raymond James $36 → $30 Maintains Strong Buy
04/29/2022 44.39% Raymond James $37 → $36 Maintains Strong Buy
04/12/2022 48.4% Raymond James $45 → $37 Maintains Strong Buy
11/10/2021 80.49% Raymond James $41 → $45 Maintains Strong Buy
11/10/2021 40.38% Credit Suisse $30 → $35 Maintains Outperform
07/29/2021 64.45% Raymond James $38 → $41 Maintains Strong Buy
07/13/2021 52.41% Raymond James $34 → $38 Maintains Strong Buy
05/11/2021 36.37% Raymond James → $34 Upgrades Outperform → Strong Buy
05/05/2021 36.37% Raymond James $33 → $34 Maintains Outperform
02/12/2021 32.36% Raymond James $32 → $33 Maintains Outperform
12/18/2020 8.29% Truist Securities → $27 Initiates Coverage On → Hold
10/13/2020 28.35% Raymond James $31 → $32 Maintains Outperform
09/23/2020 -3.74% Jefferies → $24 Initiates Coverage On → Hold
08/05/2020 8.29% JP Morgan → $27 Downgrades Overweight → Neutral
07/15/2020 24.34% Raymond James $27 → $31 Maintains Outperform
05/06/2020 12.31% Credit Suisse $31 → $28 Maintains Outperform
05/06/2020 8.29% Raymond James $26 → $27 Maintains Outperform
03/13/2020 16.32% Raymond James $33 → $29 Maintains Outperform
02/27/2020 32.36% Raymond James $34 → $33 Maintains Outperform
12/13/2019 24.34% JP Morgan $30 → $31 Upgrades Neutral → Overweight
11/07/2019 0.27% BMO Capital $24 → $25 Maintains Market Perform
10/08/2019 -3.74% BMO Capital → $24 Initiates Coverage On → Market Perform
08/12/2019 24.34% Goldman Sachs → $31 Initiates Coverage On → Buy
08/12/2019 24.34% Raymond James → $31 Initiates Coverage On → Outperform
08/12/2019 16.32% JP Morgan → $29 Initiates Coverage On → Neutral

What is the target price for AssetMark Financial Hldgs (AMK)?

The latest price target for AssetMark Financial Hldgs (NYSE: AMK) was reported by BMO Capital on November 7, 2023. The analyst firm set a price target for $32.00 expecting AMK to rise to within 12 months (a possible 28.35% upside). 9 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for AssetMark Financial Hldgs (AMK)?

The latest analyst rating for AssetMark Financial Hldgs (NYSE: AMK) was provided by BMO Capital, and AssetMark Financial Hldgs maintained their market perform rating.

When is the next analyst rating going to be posted or updated for AssetMark Financial Hldgs (AMK)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AssetMark Financial Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AssetMark Financial Hldgs was filed on November 7, 2023 so you should expect the next rating to be made available sometime around November 7, 2024.

Is the Analyst Rating AssetMark Financial Hldgs (AMK) correct?

While ratings are subjective and will change, the latest AssetMark Financial Hldgs (AMK) rating was a maintained with a price target of $33.00 to $32.00. The current price AssetMark Financial Hldgs (AMK) is trading at is $24.93, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment